Garriott's Medicolegal Aspects of Alcohol

Garriott's Medicolegal Aspects of Alcohol
Author: Yale H. Caplan
Publisher:
Total Pages: 702
Release: 2014-10-01
Genre: Law
ISBN: 9781936360888

Now available in its Sixth Edition, Garriott's Medicolegal Aspects of Alcohol is the hands-down indispensable textbook for forensic toxicology and for anyone involved with the medicolegal aspects of alcohol. This Sixth revised edition, is designed to continue to provide you with up-to-date and authoritative information on alcohol in all aspects of its involvement in the forensic sciences. The original authors have provided updated science and information in their topic areas, and new authors with special expertise have been brought on board. All topics in the original book have been revised and expanded and new sections including standardized field sobriety testing and uncertainty in blood and breath alcohol measurements have been added. The wealth of information presented in this new sixth edition makes it an invaluable resource when investigating and litigating cases involving alcohol.

Garriott's Medicolegal Aspects of Alcohol

Garriott's Medicolegal Aspects of Alcohol
Author: Erik H. Aguayo
Publisher: Lawyers & Judges Publishing
Total Pages: 0
Release: 2008
Genre: Alcohol
ISBN: 9781933264585

This fifth, revised edition continues to provide readers with authoritative information on alcohol in the forensic sciences. All areas in the original book have been revised and expanded, and new sections have been added including chapters on prosecution and defense of DUI cases.

Critical Issues in Alcohol and Drugs of Abuse Testing

Critical Issues in Alcohol and Drugs of Abuse Testing
Author: Amitava Dasgupta
Publisher: Academic Press
Total Pages: 544
Release: 2019-01-10
Genre: Science
ISBN: 0128156082

Critical Issues in Alcohol and Drugs of Abuse Testing, Second Edition, addresses the general principles and technological advances for measuring drugs and alcohol, along with the pitfalls of drugs of abuse testing. Many designer drugs, for example, are not routinely tested in drugs of abuse panels and may go undetected in a drug test. This updated edition is a must-have for clinical pathologists, toxicologists, clinicians, and medical review officers and regulators, bridging the gap between technical and clinical information. Topics of note include the monitoring of pain management drugs, bath salts, spices (synthetic marijuana), designer drugs and date rape drugs, and more. - Serves as a ready resource of information for alcohol and drug testing - Ideal resource for making decisions related to the monitoring and interpretation of results - Includes concise content for clinical laboratory scientists, toxicologists and clinicians

Forensic Pathology Reviews Vol 3

Forensic Pathology Reviews Vol 3
Author: Michael Tsokos
Publisher: Springer Science & Business Media
Total Pages: 464
Release: 2007-11-15
Genre: Medical
ISBN: 1592599109

A collection of cutting-edge accounts of special topics from various fields of forensic pathology and death scene investigation. The authors offer critical insight into the medicolegal investigation of bodies found in water, the forensic aspects of the human immunodeficiency virus (HIV)-1 infection of the central nervous system, deaths in a head-down position, and forensic bitemark analysis. Additional chapters address taphonomic changes in human bodies during the early postmortem interval, arrhythmogenic ventricular dysplaisia that produces sudden death in young people, the postmortem diagnosis of death in anaphylaxis, and iatrogenici deaths. The forensic aspects of suicide, murder-suicide, and suicide trends in the United States are also discussed, along with the evaluation of fatal pulmonary thromboembolism and the use of radiology in medicolegal investigations.

Behavioral Neurobiology of Alcohol Addiction

Behavioral Neurobiology of Alcohol Addiction
Author: Wolfgang Sommer
Publisher: Springer Science & Business Media
Total Pages: 721
Release: 2012-07-28
Genre: Medical
ISBN: 3642287204

The question how alcohol alters mood states and why this may end up becoming an addiction is puzzling alcohol researchers since decades. In this volume, an assembly of highly distinguished experts and leaders in alcohol addiction research provides lucid presentations of the current knowledge and research challenges as well as interesting viewpoints on future research directions aimed to stimulate communication and convergence between clinical and preclinical researchers, and to renew interest in the vibrant field of alcohol addiction research among a wide scientifically minded audience. Five Current Topics are discussed in this volume: Neurobiological mechanisms of alcoholism, Genetics, Clinical phenotypes and their preclinical models, Brain imaging, and Translational approaches for treatment development, both pharmacological and non-pharmacological. These areas have in our opinion brought alcohol research substantially forward and influenced our thinking about how to reach our common paramount goal, namely to offer effective treatment solutions for an extensive group of patients with largely unmet medical needs.

Guidelines for the Treatment of Alcohol Problems

Guidelines for the Treatment of Alcohol Problems
Author: Paul S. Haber
Publisher: Specialty of Addiction Medicine, Faculty of Medicine and Health, The University of Sydney
Total Pages: 408
Release: 2021-04-01
Genre: Medical
ISBN: 1742104894

The Australian Guidelines for the Treatment of Alcohol Problems have been periodically developed over the past 25 years. In 1993, the first version of these guidelines, titled: ‘An outline for the management of alcohol problems: Quality assurance in the treatment of drug dependence project’ was published (Mattick & Jarvis 1993). The Australian Government commissioned an update a decade later (Shand et al. 2003) and a further edition in 2009 to integrate the Guidelines with the Australian Guidelines to Reduce Health Risks from Drinking Alcohol (National Health and Medical Research Council, NHMRC 2009; Haber et al., 2009). The present version of the Guidelines was also commissioned by the Commonwealth of Australia to remain current and integrated with the updated NHMRC consumption guidelines (2020). In order to ensure that guidelines remain relevant, the next set of guidelines should be updated in 2025, consistent with NHMRC recommendation that guidelines be updated every five years. These guidelines aim to provide up-to-date, evidence-based information to clinicians on available treatments for people with alcohol problems and are largely directed towards individual clinicians in practice, such as primary care physicians (general practitioners, nursing staff), specialist medical practitioners, psychologists and other counsellors, and other health professionals. Some chapters highlight service or system level issues that impact on clinicians and their patients. These include recommendations concerning Aboriginal and Torres Strait Islander peoples, culturally and linguistically diverse groups, stigma, and discrimination. Elsewhere, organisation capacity is implied, such as medical resources for withdrawal management where recommendations indicate use of medications. As all forms of treatment will not be readily available or suitable for all populations or settings, these guidelines may require interpretation and adaptation.

Textbook Of Forensic Medicine And Toxicology: Principles And Practice

Textbook Of Forensic Medicine And Toxicology: Principles And Practice
Author: Vij
Publisher: Elsevier India
Total Pages: 776
Release: 2008
Genre:
ISBN: 9788131211298

The book is a comprehensive and authoritative exposition of Forensic Medicine and Toxicology. It provides precise and useful information on relevant legal provisions and forensic anatomy, and promotes interdisciplinary understanding of issues where law an medicine converge. The text is oriented towards the practical problems ncountered during day-to-day medicollegal work. About the Author : - Krishnan Vij, MD, L.L.B. is Professor and Head, Department of Forensic Medicine and Toxicology, Government Medical College & Hospital, Chandigarh, India.

The Health Effects of Cannabis and Cannabinoids

The Health Effects of Cannabis and Cannabinoids
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
Total Pages: 487
Release: 2017-03-31
Genre: Science
ISBN: 0309453070

Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk. However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively. Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agendaâ€"outlining gaps in current knowledge and opportunities for providing additional insight into these issuesâ€"that summarizes and prioritizes pressing research needs.

The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder

The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder
Author: American Psychiatric Association
Publisher: American Psychiatric Pub
Total Pages: 226
Release: 2018-01-11
Genre: Medical
ISBN: 0890426821

Alcohol use disorder (AUD) is a major public health problem in the United States. The estimated 12-month and lifetime prevalence values for AUD are 13.9% and 29.1%, respectively, with approximately half of individuals with lifetime AUD having a severe disorder. AUD and its sequelae also account for significant excess mortality and cost the United States more than $200 billion annually. Despite its high prevalence and numerous negative consequences, AUD remains undertreated. In fact, fewer than 1 in 10 individuals in the United States with a 12-month diagnosis of AUD receive any treatment. Nevertheless, effective and evidence-based interventions are available, and treatment is associated with reductions in the risk of relapse and AUD-associated mortality. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder seeks to reduce these substantial psychosocial and public health consequences of AUD for millions of affected individuals. The guideline focuses specifically on evidence-based pharmacological treatments for AUD in outpatient settings and includes additional information on assessment and treatment planning, which are an integral part of using pharmacotherapy to treat AUD. In addition to reviewing the available evidence on the use of AUD pharmacotherapy, the guideline offers clear, concise, and actionable recommendation statements, each of which is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms. The guideline provides guidance on implementing these recommendations into clinical practice, with the goal of improving quality of care and treatment outcomes of AUD.